 |
Farkas Bernadett; Limdi Jimmy K.; Bacsur Péter; Savarino Edoardo Vincenzo; Bertin Luisa; Sethi-Arora Karishma; Miheller Pál; Vilmos Fruzsina; Castiglione Fabiana; Bonacci Livio; Lukas Milan; Maharshak Nitsan; Berman Galia; Krznaric Željko; Wetwittayakhlang Panu; Lakatos Péter László; Seidelin Jakob Benedict; Attauabi Mohamed; Michalopoulos George; Ribaldone Davide Giuseppe; Kagramanova Anna; Chashkova Elena; Sarlós Patrícia; Saibeni Simone; Shitrit Ariella Bar-Gil; Borsos Mariann; Resál Tamás; Szepes Zoltán; Molnár Tamás; Farkas Klaudia:
Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study.
EXPERT OPINION ON BIOLOGICAL THERAPY, 25 (6).
pp. 669-678.
ISSN 1471-2598
(2025)
Farkas Bernadett; Resál Tamás; Lakatos Péter László; Bessissow Talat; Limdi Jimmy K.; Armuzzi Alessandro; Bezzio Cristina; Savarino Edoardo V.; Saibeni Simone; Michalopoulos George; Attauabi Mohamed; Seidelin Jakob Benedict; Fousekis Fotios S.; Katsanos Kostas; Bacsur Péter; Bálint Anita; Ivány Emese; Szepes Zoltán; Farkas Klaudia; Molnár Tamás:
Upadacitinib is associated with better clinical and biochemical outcomes than tofacitinib in refractory, moderate-to-severe UC.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY.
ISSN 1542-3565
(2025)
![[Fel]](/style/images/multi_up.png)
Vissza
